Order Article Reprints

Tura A, Pawlik VE, Rudolf M, Ernesti JS, Stutzer J-N, Grisanti S, Ranjbar M. Uptake of Ranibizumab but Not Bevacizumab into Uveal Melanoma Cells Correlates with a Sustained Decline in VEGF-A Levels and Metastatic Activities. Cancers. 2019; 11(6):868. https://doi.org/10.3390/cancers11060868

Tura, Aysegül, Vera E. Pawlik, Martin Rudolf, Justus S. Ernesti, Jan-Niklas Stutzer, Salvatore Grisanti, and Mahdy Ranjbar. 2019. "Uptake of Ranibizumab but Not Bevacizumab into Uveal Melanoma Cells Correlates with a Sustained Decline in VEGF-A Levels and Metastatic Activities" Cancers 11, no. 6: 868. https://doi.org/10.3390/cancers11060868

Tura, A., Pawlik, V. E., Rudolf, M., Ernesti, J. S., Stutzer, J.-N., Grisanti, S., & Ranjbar, M. (2019). Uptake of Ranibizumab but Not Bevacizumab into Uveal Melanoma Cells Correlates with a Sustained Decline in VEGF-A Levels and Metastatic Activities. Cancers, 11(6), 868. https://doi.org/10.3390/cancers11060868